Atlas Trials

Value of Using Pioglitazone in Chronic Myeloid Leukemia Treatment

Clinical trial NCT04883125 · COMPLETED

Trial details

NCT number
NCT04883125
Sponsor
Mansoura University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Myelogenous Leukemia, BCR-ABL PositiveCML, Chronic Phase
Start date
2018-01-01
Primary completion
2021-04-15
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.